Search For Lab Tests Here

The Postprandial Glucose Tolerance Test, 1-Hour evaluates blood glucose response one hour after eating or consuming a glucose solution. This test is commonly used to detect abnormal post-meal glucose regulation, prediabetes, and diabetes risk. Measuring the body’s ability to manage glucose following food intake offers important data on insulin function, carbohydrate handling, and metabolic balance.

The Postprandial Glucose Tolerance Test, 2-Hour evaluates glucose response two hours after eating or consuming a glucose solution. It is an important diagnostic tool for detecting abnormal post-meal glucose regulation, prediabetes, and diabetes risk. Measuring the body’s glucose clearance at this critical interval highlights insulin function, carbohydrate handling, and early metabolic dysfunction.

 The 2 Hour Fasting and Postprandial Glucose Test is a diagnostic procedure that measures the body's ability to metabolize glucose (sugar) and respond to insulin. It involves taking two blood samples: one after an overnight fast and another two hours after consuming a meal.

 The 1 Hour Fasting and Postprandial Glucose test is a two-part diagnostic evaluation that first measures the glucose level in the blood after an overnight fast and then assesses it again one hour after consuming a glucose-rich meal or drink.

The 1,5-Anhydroglucitol Intermediate Glycemic Control Test measures short- to mid-term blood sugar stability, offering an advanced indicator of daily glucose control and metabolic health. It bridges the gap between fasting glucose and HbA1c results, helping identify hidden glucose spikes that affect insulin function, diabetes management, and long-term health outcomes.

The AALP Apolipoprotein C3 Test measures apolipoprotein C-III, a key regulator of triglyceride metabolism and lipoprotein clearance. Elevated ApoC-III levels are linked to impaired triglyceride breakdown, atherogenic remnant particles, and increased cardiometabolic risk. This advanced blood test provides deeper insight beyond standard lipid panels, helping identify hidden cardiovascular and metabolic risk and supporting more personalized lipid health assessment.

The C-Peptide Test measures C-peptide levels in blood to assess insulin production and pancreatic function. Low levels may indicate type 1 diabetes or reduced insulin production, while high levels may suggest type 2 diabetes, insulin resistance, or insulinoma. Doctors use this test to differentiate diabetes types, monitor treatment, and evaluate unexplained hypoglycemia. It provides key insight into endocrine, pancreatic, and metabolic health.